These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26554440)

  • 21. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients.
    Ramakers BP; Giamarellos-Bourboulis EJ; Tasioudis C; Coenen MJ; Kox M; Vermeulen SH; Groothuismink JM; van der Hoeven JG; Routsi C; Savva A; Prekates A; Diamantea F; Sinapidis D; Smits P; Toutouzas K; Riksen NP; Pickkers P;
    Shock; 2015 Dec; 44(6):542-7. PubMed ID: 26529652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.
    Miyamoto MI; Clarke KA; Thomas GS; Belardinelli L
    Am Heart Hosp J; 2009; 7(2):E118-21. PubMed ID: 20354957
    [No Abstract]   [Full Text] [Related]  

  • 24. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.
    Lieu HD; Shryock JC; von Mering GO; Gordi T; Blackburn B; Olmsted AW; Belardinelli L; Kerensky RA
    J Nucl Cardiol; 2007 Jul; 14(4):514-20. PubMed ID: 17679059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
    Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
    Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in pharmacologic stress agents: focus on regadenoson.
    Johnson SG; Peters S
    J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson.
    Noel CV; Krishnamurthy R; Masand P; Moffett B; Schlingmann T; Cheong BY; Krishnamurthy R
    Pediatr Cardiol; 2018 Aug; 39(6):1249-1257. PubMed ID: 29748700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
    Anderson JL; Habashi J; Carlquist JF; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Hart N
    J Am Coll Cardiol; 2000 Oct; 36(4):1248-52. PubMed ID: 11028479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regadenoson stress for myocardial perfusion imaging.
    Reyes E
    Future Cardiol; 2016 Jan; 12(1):59-67. PubMed ID: 26639775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of AMPD1 genotype on blood flow response to sprint exercise.
    Norman B; Nygren AT; Nowak J; Sabina RL
    Eur J Appl Physiol; 2008 May; 103(2):173-80. PubMed ID: 18224333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching.
    Iqbal FM; Hage FG; Ahmed A; Dean PJ; Raslan S; Heo J; Iskandrian AE
    JACC Cardiovasc Imaging; 2012 Oct; 5(10):1014-21. PubMed ID: 23058068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regadenoson myocardial perfusion imaging predicts prognosis in patients with either left bundle branch block or a ventricular paced rhythm.
    Thomas GS; Taghavi A
    J Nucl Cardiol; 2021 Jun; 28(3):978-980. PubMed ID: 31385224
    [No Abstract]   [Full Text] [Related]  

  • 34. The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging.
    Thomas GS; Thompson RC; Miyamoto MI; Ip TK; Rice DL; Milikien D; Lieu HD; Mathur VS
    J Nucl Cardiol; 2009; 16(1):63-72. PubMed ID: 19152130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of regadenoson in patients with severe chronic obstructive pulmonary disease.
    Salgado-Garcia C; Jimenez-Heffernan A; Ramos-Font C; Lopez-Martin J; Sanchez-de-Mora E; Aroui T; Lopez-Aguilar R; Rivera-de-Los-Santos F; Ruiz-Frutos C
    Rev Esp Med Nucl Imagen Mol; 2016; 35(5):283-6. PubMed ID: 27160774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome.
    Hage FG; Perry G; Heo J; Iskandrian AE
    Am J Cardiol; 2010 Mar; 105(6):839-43. PubMed ID: 20211328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of regadenoson positron emission tomography stress testing in orthotopic heart transplant patients.
    Lazarus JJ; Saleh A; Ghannam M; Aaronson K; Colvin M; Pagani F; Koelling T; Corbett JR; Weinberg RL; Murthy VL; Konerman MC
    J Nucl Cardiol; 2020 Jun; 27(3):943-948. PubMed ID: 30483958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regadenoson.
    Garnock-Jones KP; Curran MP
    Am J Cardiovasc Drugs; 2010; 10(1):65-71. PubMed ID: 20063904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
    Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B
    J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AMPD1 gene polymorphism and the vasodilatory response to ischemia.
    Hand BD; Roth SM; Roltsch MH; Park JJ; Kostek MC; Ferrell RE; Brown MD
    Life Sci; 2006 Sep; 79(15):1413-8. PubMed ID: 16707139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.